|
SBDSP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.408200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.171600E-02 |
| Normal-vs-Stage2 |
3.963800E-01 |
| Normal-vs-Stage3 |
3.877000E-01 |
| Normal-vs-Stage4 |
6.437400E-01 |
| Stage1-vs-Stage2 |
7.407600E-01 |
| Stage1-vs-Stage3 |
7.699800E-03 |
| Stage1-vs-Stage4 |
2.840600E-01 |
| Stage2-vs-Stage3 |
1.372590E-01 |
| Stage2-vs-Stage4 |
6.781600E-01 |
| Stage3-vs-Stage4 |
2.878600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.196400E-02 |
| Normal-vs-AfricanAmerican |
1.595630E-01 |
| Normal-vs-Asian |
7.200800E-01 |
| Caucasian-vs-AfricanAmerican |
9.851800E-01 |
| Caucasian-vs-Asian |
4.056600E-01 |
| AfricanAmerican-vs-Asian |
4.323800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.054100E-02 |
| Normal-vs-Female |
5.786600E-01 |
| Male-vs-Female |
1.273770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.391200E-01 |
| Normal-vs-Extreme_Weight |
3.662200E-02 |
| Normal-vs-Obese |
1.444790E-01 |
| Normal-vs-Extreme_Obese |
9.599200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.061500E-02 |
| Normal_Weight-vs-Obese |
2.966800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.989800E-01 |
| Extreme_Weight-vs-Obese |
5.787800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.114000E-01 |
| Obese-vs-Extreme_Obese |
4.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.707800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.263800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.338600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.281000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.788200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.362400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.749800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.829990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.670200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.086200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.964540E-04 |
| Normal-VS-Type2 PRCC |
2.297800E-01 |
| Normal-VS-KIRP CIMP |
5.904600E-01 |
| Normal-VS-Unclassified PRCC |
9.419800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.93510000432585E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.116350E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.159300E-04 |
| Type2 PRCC-VS-KIRP CIMP |
7.055800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.104800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.536400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.761200E-01 |
| Normal-vs-N1 |
1.752850E-01 |
| Normal-vs-N2 |
9.339600E-01 |
| N0-vs-N1 |
3.956600E-01 |
| N0-vs-N2 |
8.716200E-01 |
| N1-vs-N2 |
4.868800E-01 |
|
|
